Clinical trial

Clinical Estradiol Trial in Women With Schizophrenia

NCT00206570

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2001-01-01

PhasePHASE2

Study timeline

Study start (unknown)2001-01-01Date precision: month

Registry last updated2015-02-04

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Schizophreniaunresolved

Schizoaffective Disorderunresolved

Schizophreniform Disorderunresolved

Interventions

EstradiolDRUG · verified · RxNorm: estradiol

Sponsors & collaborators

Bayside Healthlead sponsor

National Alliance for Research on Schizophrenia and Depressioncollaborator

Stanley Medical Research Institutecollaborator

National Health and Medical Research Council, Australiacollaborator

Mapped research locations

MelbourneVictoria, Australia1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00206570 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.